Robert Knight's most recent trade in Schneider National Inc - Ordinary Shares - Class B was a trade of 7,835 Class B Common Stock done . Disclosure was reported to the exchange on April 29, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Schneider National Inc - O... | Robert M. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 7,835 | 40,807 (0%) | 0% | 0 | Class B Common Stock | |
Hyliion Holdings Corporati... | Robert M. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 59,809 | 314,369 | - | 0 | Common Stock | |
Schneider National Inc - O... | Robert M. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 8,012 | 32,972 (0%) | 0% | 0 | Class B Common Stock | |
Hyliion Holdings Corporati... | Robert M. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 78,125 | 254,560 | - | 0 | Common Stock | |
Hyliion Holdings Corporati... | Robert M. Knight | Director | Purchase of securities on an exchange or from another person at price $ 0.57 per share. | 21 Nov 2023 | 100,000 | 176,435 | - | 0.6 | 57,000 | Common Stock |
Schneider National Inc - O... | Robert M. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 5,674 | 24,960 (0%) | 0% | 0 | Class B Common Stock | |
Hyliion Holdings Corporati... | Robert M. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 25,000 | 76,435 | - | 0 | Common Stock | |
Schneider National Inc - O... | Robert M. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 6,619 | 19,286 (0%) | 0% | 0 | Class B Common Stock | |
Neximmune Inc | Robert Knight | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 48,000 | 48,000 | - | - | Stock Options (Right to Buy) | |
Hyliion Holdings Corporati... | Robert M. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 31,435 | 51,435 | - | 0 | Common Stock | |
Hyliion Holdings Corporati... | Robert M. Knight | Director | Purchase of securities on an exchange or from another person at price $ 6.15 per share. | 16 Dec 2021 | 10,000 | 20,000 | - | 6.1 | 61,481 | Common Stock |
Schneider National Inc - O... | Robert M. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2021 | 6,111 | 12,667 (0%) | 0% | 0 | Class B Common Stock | |
Hyliion Holdings Corporati... | Robert M. Knight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 10,000 | 10,000 | - | 0 | Common Stock | |
Neximmune Inc | Robert Knight | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 210,609 | 210,609 | - | - | Stock Option (right to buy) |